Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Other Non-Current Assets (2023 - 2026)

Abpro Holdings' (ABPO) quarterly Other Non-Current Assets came in at $55000.0 in Q1 2026, down 16.67% YoY from $66000.0 in Q1 2025, and little changed on a QoQ basis from $55000.0 in Q4 2025.

Abpro Holdings (ABPO) Other Non-Current Assets (2023 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 4 years of Other Non-Current Assets data on file, last reported at $55000.0 in Q1 2026.

  • Quarterly Other Non-Current Assets fell 16.67% year-over-year to $55000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55000.0 (down 16.67% YoY) and the FY2025 annual result came in at $55000.0, down 61.27% from the prior year.
  • Other Non-Current Assets steadied at $55000.0 in Q1 2026, from $55000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $142000.0 in Q4 2024 to a low of $15000.0 in Q2 2025.
  • A 4-year average of $77000.0 and a median of $66000.0 in 2023 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 115.15% — and 2025, when it plunged 89.29%.
  • Tracing ABPO's Other Non-Current Assets over 4 years: stood at $66000.0 in 2023, then jumped by 115.15% to $142000.0 in 2024, then tumbled by 61.27% to $55000.0 in 2025, then changed by 0.0% to $55000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $55000.0 (Q1 2026), $55000.0 (Q4 2025), and $15000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 618.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 109.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 65.13 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 202.31 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 104.44 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 62.96 Mn
10 Abpro Holdings 1.14 Mn 1.14 Mn - 55,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 55,000.00
Dec 31, 2025 55,000.00
Sep 30, 2025 15,000.00
Jun 30, 2025 15,000.00
Mar 31, 2025 66,000.00
Dec 31, 2024 142,000.00
Sep 30, 2024 140,000.00
Jun 30, 2024 139,000.00
Dec 31, 2023 66,000.00